Header Ads

A vaccination milestone

Coronavirus Daily
Bloomberg

Here's the latest news from the global pandemic.

A vaccine milestone

The U.S. hit a record on Monday with 1.25 million vaccine doses reported in a single day. That's great news amid a rollout that's otherwise gotten off to a slow start

There are some caveats: Some of that amount almost certainly came from data catching up over the weekend, when the U.S. Centers for Disease Control and Prevention and some states don't report. (Bloomberg runs a daily tracker of vaccinations in the U.S. and around the globe, which you can find here.) 

So is it a one-day bump, or a bend in the curve? The next few days of data should provide the answer. The holidays are over and states have had four weeks to get through the early start-up pains of running the programs. The pace of vaccinations will either keep growing, or stall out and reveal more troubles with the effort. 

Some states are doing better (dark green) than others.

It's already clear that some states are doing better than others.

Bloomberg tracks the percentage of doses shipped to states that have been used. The best, like the Dakotas, Connecticut and West Virginia, usually report that they've moved through 60% to 70% of their stock. The worst are using only a fraction of that: Alabama, Georgia and North Carolina have, as of Monday, used only 20% to 30% of the doses shipped to them. (The percentages shift as doses are shipped out and vaccines are administered, but there's been a consistent trend among most of the leaders and laggards.) 

A million doses in a day is a record, and it's a good start. But there are about 330 million people in the U.S. The vaccines now authorized for U.S. use require two doses each. To get to 75% coverage of the population, it will take 495 million doses. To do that by the end of August, for example, the U.S. needs to be doing not one million doses a day, but more than double that.--Drew Armstrong

Latest podcast

What Allergic Reactions Mean for You

As vaccinations roll out, a few people have incurred serious allergic reactions. Though the rate is very low, it is still higher than that for the seasonal flu vaccine. Despite that, the CDC says most should still get the shots. Emma Court explains why. Get the episode here.

 

What you should read

Besieged U.K. Hospitals Are Vaccine Lag Warning
Worries mutation will spread faster than lagging vaccinations can keep up.
Philippines May Tap Meat, Fish Freezers for Shots
Nation to ramp up cold chain capacity as vaccines require low temperature.
Johnson's Bike Ride Outing Risks Own Lockdown 
Boris Johnson's office was unable to supply a statement explaining his trip.
China Shot's Four (Wildly) Different Efficacy Rates
Uncertainty swirls over the efficacy of leading Chinese Covid-19 vaccine.
NYC's Complex Vaccine Sign-Up Baffles Elderly
Many were foiled by daunting array of technical problems, website glitches.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments